Travis Johnson, Stock Gumshoe

Author Bio

Travis Johnson, Stock Gumshoe
Travis Johnson is an individual investor who founded Stock Gumshoe in 2007 as a way to air his dissections of overhyped marketing pitches... and to share the "secret" stocks that stock newsletters hype to get your attention and your subscription dollars. His thinking? If you already know what the "secret" stock is, you can make a much more reasonable and thoughtful decision about whether or not to commit to an expensive newsletter subscription. (And if you don't pay for the info, you'll be more free to think for yourself about whether or not the investment is worth your money.) In his charmed life he has been, among other things, a university faculty member, a fundraiser, a writer, and a world-champion ice-cream scooper. Now he runs Stock Gumshoe for you, allowing us all to discuss and dissect the latest overheated stock ideas... as well as review and talk about investment newsletters and enjoy the commentary and opinions of Stock Gumshoe's other special contributors and the discussion with our unusually attractive, erudite and polite readers. He lives with Mrs. Gumshoe and all their little Gumshoes in the wilds of Western Massachusetts.

Author Archives

IPO Insider

High end monthly newsletter recommending IPOs, promoted as using a proprietary system to identify the best 10 or so newly public stocks to invest in during a given year. Spittler previously worked on International Speculator for Casey Research.

True Momentum

One of half a dozen Paul Mampilly-connected newsletters at Banyan Hill, this one is a “trading service” that attempts to pick a couple midsize stocks each month that have “true momentum” (which seems to be a qualitative assessment of the business prospects, not a market momentum measure).

What’s the “Single-Stock Retirement Plan?” Crowdability teases that “Starting Jan. 7th, This Tiny $3 Stock Could Ignite a $20 Trillion Bull Market…”

This ad has been running for a week or so, since Crowdability hosted their “special presentation” to make the original pitch on October 23, and readers have been peppering me with questions… which makes sense, the idea of a “single stock retirement plan” is very compelling (Oxford Club has used it to pitch a different […]

Recent Author Comments

On Eric Wade's "September 12" Cryptocurrency Pitch for Stansberry
Taking investment advice from Ron Paul hasn't necessarily been a great strategy in the past, but I haven't looked into that particular new crypto. I will tell you, without knowing what little crypto it might be, that I'd go in very skeptical.[...]
On What's the "Artificial Intelligence 'Stealth ID' Technology" Stock Being Teased by Outsider Club?
LOL “Dream Crusher”. If I ever get a tattoo, that might be it![...]
On "The Other Search Giant" teased by Justin Spittler
FYI, there's a new version of the ad pitch that includes John Chambers (legendary former CEO of Cisco) saying that he's found “one of the hot stocks of the next decade” -- and Chambers is on the board of the company as well. That's just another refer[...]
On "Immortality Switch" -- What's Kramer's "$6 Anti-Aging Stock?"
Yes, they're talking up UBX too.[...]
On Friday File: Sad Lasers, Disappointing Hemp and too many Mutual Funds
I've looked at it a few times along the way, as they've dramatically changed their business when easy financing dried up for pot stocks and sales growth has not emerged like they expected. Will try to look into it more later in the week, haven't really d[...]
On "The Other Search Giant" teased by Justin Spittler
Thanks Tony. I'm looking into maybe trying it for Stock Gumshoe -- it would be hard for our search to be much worse :)[...]
On "Immortality Switch" -- What's Kramer's "$6 Anti-Aging Stock?"
Wait, a limit? But that doesn’t apply to billionaires, right? Are you saying both that you can’t take it with you, and that you have to leave this mortal coil anyway? So cruel![...]
On "Immortality Switch" -- What's Kramer's "$6 Anti-Aging Stock?"
I’ve been meaning to check up on that one — I guess they didn’t make an announcement that changed the world on November 13, huh? My older coverage of that one, including some previous bs “day zero” dates, is here if anyone else is curious: [...]
On "Immortality Switch" -- What's Kramer's "$6 Anti-Aging Stock?"
Thanks![...]
On "Immortality Switch" -- What's Kramer's "$6 Anti-Aging Stock?"
The quick shorthand is “no approved drugs” and little or no revenue. That surge was mostly because the company is small, the market very large, and current drugs don’t help many people... so the potential just got better because the trial results we[...]
On Friday File: Sad Lasers, Disappointing Hemp and too many Mutual Funds
Hemp is fully legal to grow and process, but CBD is the active ingredient in an approved pharmaceutical (Epidiolex), so the FDA is dithering over whether to allow any use of it in consumables as a dietary supplement. I don’t think CBD lotions or creams [...]
On What's this "Founder's share Certificate" for a Space Investment?
That’s true, they are way behind Branson’s original goal. Which is partly why I say he’s somewhat Musk-ian.[...]
On What's this "Founder's share Certificate" for a Space Investment?
Boeing did just invest a chunk into Virgin Galactic, though I don't know if they have any partners or large suppliers helping with the actual airframe or if it's all VG -- I think their orbital ship is based on the original SpaceShipOne that won the X priz[...]
On Matt McCall's "300X Your Money" on Chinese Biotech Pitch
True, the home listing is in Hong Kong at ticker 6160, where the price is about HK$117 as of the last close -- at the last rate I checked, that would be $14.96 in US$, and each US ADR (BGNE) does represent 13 HK shares so that would be a fair price of $194[...]
On Matt McCall's "300X Your Money" on Chinese Biotech Pitch
Cancer rates are also aided by the fact that people are growing wealthier, getting more health care attention, and having their cancer diagnosed. China seems to be stuck right now in that transition from cancers that plague poorer countries (those caused [...]
On "'Cut & Paste' Disease From Your Body" --- what's this "Living Software" Business from Dylan Jovine?
We keep seeing this ad and getting more questions about it -- the ad hasn't changed in any big way that I've noticed, though they've dropped some of the clues. Just FYI, here's the performance of the three main CRISPR stocks since we published this teaser[...]
On Three more "Secret" Stocks for this "50X" opportunity
Excellent point, that small AUM is definitely a risk.[...]
On Three more "Secret" Stocks for this "50X" opportunity
The Terminator is scarier than 2, but not better! I confess to enjoying "fun" more than "noir" :)[...]
On Matt McCall's "300X Your Money" on Chinese Biotech Pitch
Good work! I agree on Ascletis, went into them and the other two in today's new article here.[...]
On "Day Zero" -- What's Jeff Siegel talking about when he says, "November 13th, 2019 will be the most profitable day in the history of mankind."
NOK topped out around $6.70, but yes, has been a big loser since then.[...]

This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

Connect with Travis

website designed by Gravity Switch